7 Key Facts About Shot of Glucagon: Product Composition and Uses
Published: 18 7 月, 2026 16:05
Author: Jason Moreau
Abstract: Glucagon injection, a critical peptide hormone, reverses severe hypoglycemia by mobilizing hepatic glucose stores. Composed of a 29-amino acid polypeptide, its market is expanding at a 6.8% CAGR (2024-2030), driven by diabetes prevalence and emergency kit demand. Key brands (Eli Lilly’s Glucagon, Xeris’s Gvoke) differ in reconstitution vs. ready-to-use formats. Advantages include rapid onset (10-15 min); disadvantages include short shelf life and nausea. Regulatory compliance (FDA/EMA) and cold-chain logistics (2-8°C) are critical. Selection hinges on stability, dosage accuracy, and patient ease-of-use.